The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects

NCT00856609 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

NIH

Sponsor class

Conditions

Weight Loss
Obesity

Interventions

DRUG: Byetta (exenatide)
BEHAVIORAL: Weight loss
OTHER: Metabolic Chamber
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)